MSH2 and adrenal cortex carcinoma: McCabe et al. reported an ACC case where ctDNA analysis was used to monitor tumor recurrence aimed at the detection of a somatic MSH2 deletion that was identified in the ACC tissue as a pathogenic driver mutation.